<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        13-828-20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PROSTIN E2 VAGINAL TAB. 3MG
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DINOPROSTONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Vaginal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Vaginal tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Restricted
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        174.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Sanico NV" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Sanico NV
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Pfizer S.A 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G02AD02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Prostin E2 Vaginal Tablets contain the prostaglandin dinoprostone and are used to &ldquo;induce&rdquo; labour. This means that the medicine will help your uterus (womb) to start contracting and you will go into labour. Dinoprostone is similar to the natural &lsquo;E2&rsquo; type of prostaglandins which are made in your body when labour starts. It will only be given to you in a hospital or clinic which has a specialised obstetric unit.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Most women can be treated with Prostin E2 Vaginal Tablets. Some women may need extra checks during treatment and for some women a different treatment may be better. Your doctor or midwife will ask you questions before giving you Prostin E2 Vaginal Tablets to make sure they are safe for you. If you do not understand any of the questions, ask your doctor or midwife to explain.</p><p>&nbsp;</p><p><strong>Do not use Prostin E2 Vaginal Tablets:</strong></p><ul><li>If you are allergic to dinoprostone or any other prostaglandin or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include wheezing, breathlessness, swelling of the hands, face, itchy rash or redness of the skin.</li></ul><p>&nbsp;</p><p>Your doctor or midwife will not use Prostin E2 Vaginal Tablets to start or strengthen your labour in certain circumstances if:</p><ul><li>you have had a Caesarean section or any major surgery to your womb.</li><li>you have been told that your baby is too big for your pelvis, is lying awkwardly or may be physically stressed.</li><li>you had a difficult labour or traumatic delivery in a previous pregnancy.</li><li>you have an infection of your womb, ovaries or tubes (pelvic inflammatory disease) unless you are receiving treatment for these, or if you have ever had such an infection in the past.</li><li>you have been told that you have or might have placenta praevia (where the placenta lies across the entrance to the womb, rather than being high up and out of the way during birth). This causes bleeding from the vagina during pregnancy and may require that your baby is delivered by Caesarean section.</li><li>you have had unexplained bleeding from the vagina or spotting at any time during your pregnancy.</li><li>you have current heart, lung, kidney or liver disease.</li></ul><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or midwife before they use this medicine if you have or have had in the past any of the following conditions as they may want to monitor you more closely:</p><p>&nbsp;</p><ul><li>heart, lung, kidney or liver disease</li><li>glaucoma (raised pressure in the eye)</li><li>epilepsy</li><li>suffered from asthma</li><li>hypertension (high blood pressure) at any time, including during this or any previous pregnancy</li><li>been told you had abnormally strong contractions of your womb during a previous labour</li><li>scarring of your womb from a previous operation</li><li>are you 35 years or older?</li><li>is your pregnancy over 40 weeks?</li><li>do you have any complications related to this pregnancy?</li><li>an increased risk of developing a generalised bleeding disorder, a condition known as post-partum disseminated coagulation</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are having more than one baby</p><ul><li>if your water has broken.</li></ul><p>&nbsp;</p><p>Your doctor or midwife will ask you questions before giving you Prostin E2 Vaginal Tablets to make sure they are safe for you.</p><p>&nbsp;</p><p>If you do not understand any of the questions, ask your doctor or midwife to explain.</p><p>&nbsp;</p><p><strong>Other medicines and Prostin E2 </strong><strong>Vaginal Tablets </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p><strong>&nbsp;</strong></p><p>Prostin E2 Vaginal Tablets can make you more sensitive to another medicine called oxytocin which is used to strengthen contractions. Medical staff will normally try not to use this medicine at the same time as Prostin E2 Vaginal Tablets. If you need this medicine, your doctor or midwife will make sure they are not given to you close together and will watch over the contractions very carefully.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding </strong></p><p>Prostin E2 Vaginal Tablets will only be given to you in the late stages of pregnancy to induce labour.</p><p>&nbsp;</p><p>Although prostaglandins are present in breast-milk they will not harm your baby and you may breast-feed as normal after delivery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Prostin E2 Vaginal Tablets will be given to you by a trained professional in a hospital or clinic where facilities for monitoring you and your baby are available. Before you are given this medicine, you will be examined by your doctor or midwife. They need to know the position of your baby&rsquo;s head and how dilated (wide) your cervix (neck of the womb) is.</p><p>&nbsp;</p><p>The first dose is one tablet placed high up in the vagina. If you have not had any contractions after 6 hours, a second tablet may be used. You should not be given any more tablets for 24 hours.</p><p>&nbsp;</p><p>The doctor or nurse will keep a very close eye on you during your treatment to make sure that the contractions do not become too strong<strong>, </strong>as this could cause your uterus to tear. They should be able to act quickly if you have side effects or if your womb reacts too strongly to the dose you are given. You might just need a lower dose, or you might need some other obstetric procedure.</p><p><strong>&nbsp;</strong></p><p>Your doctor or midwife will do internal checks to make sure that your cervix is opening enough. They will also check your contractions (to make sure that they are not too strong) and your baby (to make sure they do not get distressed).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>If you have asthma, Prostin E2 Vaginal Tablets could cause you to have an asthmatic attack by causing a narrowing of your airways (bronchospasm). <strong>You must tell your doctor or midwife if you suffer from asthma or if you have difficulty breathing.</strong></p><p>&nbsp;</p><p><strong>Very common</strong><strong>: may affect more than 1 in 10 people</strong></p><ul><li>Vomiting (being sick)</li><li>Slowing or quickening of the baby&rsquo;s heart rate and distress in the baby</li></ul><p>&nbsp;</p><p><strong>Common: may affect up to 1 in 10 people </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea (feeling sick)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Back pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems (distress) for the unborn child</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormally strong, frequent or long contractions of the womb</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching, soreness, rash or feeling of warmth of the vaginal area</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High body temperature (fever)</p><p>&nbsp;</p><p><strong>Rare: may affect up to 1 in 1 000 people </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal blood clotting throughout the body&rsquo;s blood vessels</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><p>As prostaglandins make the body go into labour in the same way as it would happen naturally, anything that can happen in a natural labour can also happen if you have been given Prostin E2 Vaginal Tablets. This includes:</p><ul><li>Serious allergic (hypersensitive) reactions with widespread effects such as shortness of breath, skin rashes and low blood pressure including anaphylactic shock - sudden, severe allergic reaction with breathing difficulty, swelling, lightheadedness, fast heartbeat, sweating and loss of consciousness</li><li>Heart attack (cardiac arrest)</li><li>High blood pressure&nbsp;</li><li>Asthma</li><li>Excessive contraction of the airway muscles causing breathing difficulty (bronchospasm)</li><li>Diarrhoea</li><li>Rash</li><li>Tearing of the womb</li><li>Placenta becoming detached</li><li>Sudden blockage of a blood vessel with amniotic fluid (the fluid which surrounds the baby) or by blood clots in the lungs. This could cause chest pain and shortness of breath</li><li>Very quick opening of the cervix</li><li>Breathing problems for the baby (neonatal distress)</li><li>Foetal death, stillbirth and death of the newborn baby (neonatal death); especially following serious events such as tearing of the womb</li><li>Irritation</li><li>Pain</li><li>Low Apgar score &ndash; a baby born with an Apgar score lower than seven. The Apgar score, which is measured on a scale of one to ten, is used to describe the baby&rsquo;s condition at birth. A low Apgar score means that the baby&rsquo;s heart or lungs are not working properly</li></ul><p>&nbsp;</p><p><strong>If you get any of these symptoms please tell your doctor or midwife straight away.</strong></p><p>&nbsp;</p><p>Talk to your doctor or midwife about this if you want to know more, as they will be able to give you the information that you need.</p><p>&nbsp;</p><p>Studies have shown proliferation (thickening) of bone in new-born infants who have been treated with prostaglandins for a long time. There is no evidence that this occurs following short-term treatment with Prostin E2 Vaginal Tablets.</p><p>&nbsp;</p><p>A higher risk of a generalised bleeding disorder following delivery (post-partum disseminated intravascular coagulation-DIC) has been described in women who:</p><ul><li>are aged 35 and above</li><li>whose pregnancies are more than 40 weeks</li><li>who have pregnancy-related complications</li></ul><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, or you are worried about anything unusual happening during your labour, talk to your doctor, midwife or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To report side effects: </strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Centre (NPC)</strong></p><ul><li>SFDA Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</li></ul></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p><em>&nbsp;</em></p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p><strong>&nbsp;</strong></p><p>Prostin E2 Vaginal Tablets will not be given to you after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>The hospital pharmacist will store this medicine in a refrigerator at 2-8 &deg;C.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is dinoprostone. Each tablet contains 3 mg of dinoprostone.</p><p>The other ingredients are lactose, microcrystalline cellulose, maize starch, magnesium stearate and Colloidal Anhydrous Silica.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Each pack contains blister packs of 4 tablets. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>Pfizer S.A, Brussels, Belgium</p><p>&nbsp;</p><p><strong>Manufacturer</strong></p><p>Sanico NV, Belgium</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                February 2024.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>&nbsp;</strong>تحتوي أقراص بروستين إي 2 المهبلية على البروستاجلاندين دينوبروستون وتستخدم لتحفيز المخاض. ويعني هذا أن الدواء سوف يساعد رحمكِ على البدء في الانقباض والدخول في مرحلة المخاض. دينوبروستون يشبه النوع &quot;إي 2&quot; من البروستاجلاندينات الطبيعية التي يتم تصنيعها في جسمكِ عند بدء المخاض. سوف يتم إعطاؤه لكِ في إحدى المستشفيات أو العيادات ذات وحدات الولادة المتخصصة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table dir="rtl" border="1" cellspacing="0" cellpadding="0" align="right" style="width:100%"><tbody><tr><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن علاج أغلب السيدات باستخدام أقراص بروستين إي ٢ المهبلية. يمكن أن تحتاج بعض السيدات إلى الخضوع لمزيد من الفحوصات أثناء العلاج ويمكن أن يكون من الأفضل لبعض السيدات استخدام علاج مختلف. سوف يطرح عليكِ طبيبكِ أو القابلة أسئلة قبل إعطائكِ أقراص بروستين إي ٢ المهبلية للتأكد من أنها آمنة بالنسبة لكِ. إذا لم تفهمي أي من الأسئلة، فاطلبي من طبيبكِ أو القابلة القيام بالتوضيح.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>موانع استعمال</strong><strong> أقراص بروستين إي ٢ المهبلية</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ مصابة بالحساسية تجاه دينوبروستون أو أي بروستاجلاندين آخر أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم ٦). إذا أصبتِ بعلامات لتفاعل حساسية تتضمن الأزيز، أو ضيق التنفس، أو تورم اليدين أو الوجه، أو الطفح الجلدي المثير للحكة، أو احمرار الجلد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لن يستخدم طبيبكِ أو القابلة أقراص بروستين إي ٢ المهبلية لبدء أو تقوية المخاض لديكِ في بعض الحالات إذا:</p><ul><li dir="RTL">كنتِ قد خضعتي لولادة قيصرية أو أي جراحة كبرى أخرى في الرحم.</li><li dir="RTL">كنتِ قد تم إخباركِ بأن طفلكِ كبير للغاية بالنسبة لحجم الحوض لديكِ، أو متموضع بشكل غير ملائم، أو قد يكون مجهد جسديًا.</li><li dir="RTL">كنتِ قد مررتي بمخاض صعب أو ولادة عسيرة في حمل سابق.</li><li dir="RTL">كنتِ مصابة بعدوى في الرحم أو المبيضين أو قناتي فالوب (مرض التهابي بالحوض) إلا إذا كنتِ تتلقين علاجًا لهذه الحالات، أو إذا كان قد سبق لكِ أن أصبتِ بهذه العدوى في السابق.</li><li dir="RTL">كان قد تم إخباركِ بأنكِ تعانين أو قد تكونين تعانين من المشيمة المنزاحة (حيث تمتد المشيمة عبر مدخل الرحم، بدلًا من أن تكون في موضع مرتفع وبعيدًا عن مدخل الرحم أثناء الولادة). تسبب هذه الحالة حدوث نزيف من المهبل أثناء الحمل وقد تستلزم ولادة طفلكِ عن طريق إجراء ولادة قيصرية.</li><li dir="RTL">كنتِ تعانين من نزيف غير معروف السبب من المهبل أو بقع من الدم في أي وقت خلال الحمل.</li><li dir="RTL">إذا كنتِ مصابة بمرض حالي في القلب، أو الرئة، أو الكلى، أو الكبد.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال أقراص بروستين إي ٢ المهبلية</strong></p><p dir="RTL">تحدثي إلى طبيبكِ أو القابلة قبل أن يستخدما هذا الدواء إذا كنتِ مصابة بأي من الحالات التالية أو كنتِ قد أصبتِ بأي منها في السابق حيث قد يرغبان في مراقبة حالتكِ عن كثب بشكل أكبر:</p><p dir="RTL">&nbsp;</p><ul><li dir="RTL">مرض في القلب، أو الرئة، أو الكلى، أو الكبد</li><li dir="RTL">الزرق (ارتفاع الضغط داخل العين)</li><li dir="RTL">الصرع</li><li dir="RTL">عانيتِ من الربو</li><li dir="RTL">ارتفاع ضغط الدم (ضغط الدم المرتفع) في أي وقت، بما في ذلك أثناء هذا الحمل أو أي حمل سابق</li><li dir="RTL">تم إخباركِ بأنكِ أصبتِ بانقباضات قوية بشكل غير طبيعي بالرحم أثناء مخاض سابق</li><li dir="RTL">وجود تندب في رحمكِ من عملية سابقة</li><li dir="RTL">هل أنتِ بعمر ٣٥ عامًا أو أكبر؟</li><li dir="RTL">هل بلغت فترة حملكِ أكثر من ٤٠ أسبوعًا؟</li><li dir="RTL">هل تعانين من أي مضاعفات مرتبطة بهذا الحمل؟</li><li dir="RTL">وجود خطر متزايد للإصابة باضطراب نزيف معمم، وهو حالة تعرف باسم التخثر المنتشر بعد الولادة</li><li dir="RTL">إذا كنت ستلدين أكثر من طفل واحد</li><li dir="RTL">إذا نزل ماء الرحم لديكِ.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">سوف يطرح عليكِ طبيبكِ أو القابلة أسئلة قبل إعطائكِ أقراص بروستين إي ٢ المهبلية للتأكد من أنها آمنة بالنسبة لكِ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تفهمي أي من الأسئلة، فاطلبي من طبيبكِ أو القابلة القيام بالتوضيح.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية.</strong><strong> </strong></p><p dir="RTL">أخبري طبيبكِ أو الصيدلي إذا كنتِ تتناولين أو تناولتِ مؤخرًا أو قد تتناولين أي أدوية أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن تجعلكِ أقراص بروستين إي ٢ المهبلية أكثر حساسية تجاه دواء آخر يسمى أوكسيتوسين الذي يستخدم لتقوية الانقباضات. سوف يحاول الطاقم الطبي في الطبيعي عدم استخدام هذا الدواء في الوقت نفسه مع أقراص بروستين إي ٢ المهبلية. إذا كنتِ بحاجة إلى هذا الدواء، فسوف يحرص طبيبكِ أو القابلة على عدم إعطائهما إليكِ بشكل متقارب وسوف يراقبان الانقباضات بعناية شديدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">سوف يتم إعطاء أقراص بروستين إي ٢ المهبلية إليكِ فقط في المراحل الأخيرة من الحمل لتحفيز المخاض.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">على الرغم من وجود البروستاجلاندينات في لبن الثدي، فإنها لن تسبب الأذى لطفلكِ ويمكنكِ إرضاعه رضاعة طبيعية بشكل طبيعي بعد الولادة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">سيتم إعطاؤكِ أقراص بروستين إي ٢ المهبلية بواسطة أخصائي مدرب في مستشفى أو عيادة حيث تتوفر وسائل لمراقبتكِ أنتِ وطفلكِ. قبل إعطائكِ هذا الدواء، سيتم فحصكِ من قبل طبيبكِ أو القابلة. سوف يحتاجان إلى معرفة موضع رأس طفلكِ ومدى اتساع عنق الرحم لديكِ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعة الأولى هي قرص واحد يوضع بالأعلى في المهبل. إذا لم تصابي بأي انقباضات بعد ٦ ساعات، فقد يتم استخدام قرص آخر. ينبغي ألا يتم إعطاؤكِ أي أقراص إضافية لمدة ٢٤ ساعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سوف يراقب الطبيب أو الممرضة حالتكِ عن كثب أثناء العلاج للتأكد من أن الانقباضات لم تصبح أقوى من اللازم<strong>، </strong>حيث قد يسبب ذلك تمزق الرحم. ينبغي أن يكونا قادرين على التصرف بشكل سريع إذا أصبتِ بآثار جانبية أو تفاعل رحمكِ بصورة أقوى من اللازم تجاه الجرعة المعطاة لكِ. قد تحتاجين فقط إلى جرعة أقل أو قد تحتاجين إلى الخضوع إلى شكل آخر من أشكال إجراءات الولادة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سوف يجري طبيبكِ أو القابلة فحوصات داخلية للتأكد من أن عنق الرحم لديكِ متسع بما يكفي. سوف يقومان أيضًا بفحص الانقباضات لديكِ (للتأكد من أنها ليست أقوى من اللازم) وبفحص طفلكِ (للتأكد من عدم إصابته بالإجهاد).</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">كما هو الحال مع جميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، إلا أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنتِ مصابة بالربو، فقد تسبب أقراص بروستين إي ٢ المهبلية إصابتكِ بنوبة ربو عن طريق التسبب في تضييق المسالك الهوائية لديكِ (التشنج القصبي). <strong>يجب عليكِ إخبار طبيبكِ أو القابلة إذا كنتِ تعانين من الربو أو إذا كنتِ تعانين من صعوبة في التنفس.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة جدًا</strong><strong>: قد تصيب أكثر من امرأة واحدة من بين كل ١٠ نساء </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القيء (التقيؤ)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بطء أو سرعة معدل نبضات القلب لدى الطفل وإجهاد الطفل</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة: قد تصيب ما يصل إلى امرأة واحدة من بين كل ١٠ نساء</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الغثيان (الشعور بالرغبة في التقيؤ)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الظهر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات (إجهاد) للجنين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انقباضات قوية أو متكررة أو طويلة بشكل غير طبيعي بالرحم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإصابة بالحكة، أو التوجع، أو الطفح الجلدي، أو الشعور بالدفء في منطقة المهبل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع درجة حرارة الجسم (الحمى)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة: قد تصيب ما يصل إلى امرأة واحدة من بين كل ١٠٠٠ امرأة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تخثر غير طبيعي للدم في الأوعية الدموية للجسم</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ذات معدل تكرار غير معروف: لا يمكن تقدير معدل التكرار من البيانات المتاحة</strong></p><p dir="RTL">نظرًا لأن البروستاجلاندينات تجعل الجسم يدخل في مرحلة المخاض بالصورة نفسها التي تحدث طبيعيًا، فإن أي أمر يمكن أن يحدث في المخاض الطبيعي يمكن أن يحدث أيضًا إذا كان قد تم إعطاؤكِ أقراص بروستين إي ٢ المهبلية. ويتضمن ذلك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية (مفرطة التحسس) خطيرة بتأثيرات واسعة الانتشار مثل ضيق التنفس والطفح الجلدي وضغط الدم المنخفض، بما في ذلك الصدمة التأقية &ndash; تفاعل حساسية مفاجئ وشديد مع صعوبة في التنفس وتورم ودوخة ونبضات قلب سريعة وعرق وفقدان الوعي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأزمة القلبية (السكتة القلبية)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضغط الدم المرتفع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الربو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انقباض عضلات المسالك الهوائية بشكل مفرط مما يسبب صعوبة في التنفس (التشنج القصبي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تمزق الرحم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انفصال المشيمة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد مفاجئ في أحد الأوعية الدموية بالسائل السلوي (السائل الذي يحيط بالطفل) أو بسبب الجلطات الدموية في الرئتين. يمكن أن يسبب ذلك ألم الصدر وضيق التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتساع عنق الرحم بشكل سريع للغاية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات في التنفس لدى الطفل (الضائقة التنفسية لدى حديثي الولادة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; موت الجنين وولادة جنين ميت وموت الطفل المولود (وفاة حديثي الولادة)؛ خاصة بعد الأحداث الخطيرة مثل تمزق الرحم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهيج</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الألم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; درجة منخفضة وفقًا لمقياس أبجارولادة الطفل بدرجة أقل من سبعة وفقًا لمقياس أبجار. تستخدم درجة أبجار، التي يتم حسابها على مقياس من واحد إلى عشرة، لوصف حالة الطفل عند الولادة. يعني الحصول على درجة منخفضة وفقًا لمقياس أبجار أن رئتي الطفل أو قلبه لا يعمل بشكل صحيح</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبتِ بأي من هذه الأعراض، يرجى إخبار طبيبكِ أو القابلة على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدثي إلى طبيبكِ أو القابلة بشأن هذا الأمر إذا كنتِ ترغبين في معرفة المزيد، حيث سيكونان قادرين على إعطائكِ المعلومات التي تحتاجينها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أظهرت الدراسات حدوث تكاثر (زيادة كثافة) العظام في حديثي الولادة الذين تم علاجهم باستخدام البروستاجلاندينات لوقت طويل. لا يوجد دليل على حدوث ذلك بعد العلاج قصير الأمد باستخدام أقراص بروستين إي ٢ المهبلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لقد تم وصف وجود خطر أكبر للإصابة باضطراب نزيف معمم بعد الولادة (التخثر المنتشر داخل الأوعية الدموية (DIC) بعد الولادة) في السيدات اللاتي:</p><ul><li dir="RTL">يبلغن من العمر ٣٥ عامًا وأكبر</li><li dir="RTL">تخطت فترة حملهن ٤٠ أسبوعًا</li><li dir="RTL">يعانين من مضاعفات مرتبطة بالحمل</li></ul><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا أصبتِ بأي آثار جانبية، فتحدثي إلى طبيبكِ أو الصيدلي أو الممرضة. يتضمن هذا أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنكِ أيضًا الإبلاغ عن الآثار الجانبية مباشرةً (انظري التفاصيل أدناه). بالإبلاغ عن الآثار الجانبية، يمكنكِ المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية: </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL">المركز الوطني للتيقظ الدوائي (NPC)</p><ul><li dir="RTL">مركز الاتصال الموحد: 19999</li><li dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa/</li></ul></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>يُرجى الاتصال بالمؤسسات والهيئات الوطنية المختصة في كل دولة.</em></p></td></tr></tbody></table></td></tr></tbody></table><table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>&nbsp;</strong></p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">احتفظي بهذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لن يتم إعطاؤكِ أقراص بروستين إي ٢ المهبلية بعد تاريخ انتهاء الصلاحية المدون على العبوة الكرتونية بعد الرمز &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">سوف يقوم الصيدلي بالمستشفى بتخزين هذا الدواء في البراد (الثلاجة) عند درجة حرارة تتراوح بين درجتين مئويتين و٨ درجات مئوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلصي من أي أدوية عبر مياه الصرف أو مع المخلفات المنزلية. اسألي الصيدلي عن كيفية التخلص من الأدوية التي لم تعودي تستخدمينها. ستساعد هذه الإجراءات في حماية البيئة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">المادة الفعالة هي دينوبروستون. يحتوي كل قرص على ٣ ملجم من دينوبروستون.</p><p dir="RTL">المكونات الأخرى هي لاكتوز، والسيليولوز البلوري المكروي، ونشا الذرة، وستيارات المغنسيوم، والسيليكون الغرواني اللامائي.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">تحتوي كل عبوة على شرائط بليستر بها ٤ أقراص.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>مالك تصريح التسويق</strong></p><p dir="RTL">Pfizer SA, Brussels, Belgium</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجهة المصنعة</strong></p><p dir="RTL">Sanico NV</p><p dir="RTL">&nbsp;Belgium بلجيكا</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير/شباط ٢٠٢٤.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prostin E2 Vaginal Tablets 3mg.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 3 mg dinoprostone.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Vaginal tablet.

White tablet, embossed with Upjohn 715 on one side and plain on the other.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oxytocic agent. Prostin E2 Vaginal Tablets are indicated for the induction of labour, especially in patients with favourable induction features, when there are no foetal or maternal contra-indications.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Usage is restricted to qualified health care professionals and to hospitals and clinics with specialised obstetric units with facilities for continuous monitoring.</p><p>&nbsp;</p><p>The recommended dose should not be exceeded, and the dosing interval should not be shortened as this increases the risk of uterine hyperstimulation, uterine rupture, uterine haemorrhage, foetal and neonatal death.</p><p>&nbsp;</p><p><u>Posology</u></p><p>&nbsp;</p><p><em>Adults</em></p><p>&nbsp;</p><p>One tablet to be inserted high into the posterior fornix. A second tablet may be inserted after six to eight hours if labour is not established. Maximum dose 6 mg.</p><p>&nbsp;</p><p><em>Elderly</em></p><p>&nbsp;</p><p>Not applicable.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>&nbsp;</p><p>Not applicable.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p><em><u>&nbsp;</u></em></p><p>Vaginally. The tablets should be inserted high into the posterior fornix.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. 
Prostin E2 Vaginal Tablets should not be used where the patient is sensitive to prostaglandins or other constituents of the tablet.

Prostin E2 Vaginal Tablets are not recommended in the following circumstances:
•	For patients in whom oxytocic drugs are generally contra-indicated or where prolonged contractions of the uterus are considered inappropriate such as:
-	Cases with a history of Caesarean section or major uterine surgery.
-	Cases where there is cephalopelvic disproportion.
-	Cases in which foetal malpresentation is present.
-	Cases where there is clinical suspicion or definite evidence of pre-existing foetal distress.
-	Cases in which there is a history of difficult labour and/or traumatic delivery.
•	In patients with a past history of, or existing, pelvic inflammatory disease, unless adequate prior treatment has been instituted.
•	In patients where there is clinical suspicion or definite evidence of placenta praevia or unexplained vaginal bleeding during this pregnancy.
•	Patients with active cardiac, pulmonary, renal or hepatic disease.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>This product is only available to hospitals and clinics with specialised obstetric units and should only be used where 24-hour resident medical cover is provided.</strong></p><p>&nbsp;</p><p>Use caution in handling this product to prevent contact with skin. Wash hands thoroughly with soap and water after administration.</p><p>&nbsp;</p><p>As with any oxytocic agent, the risk of uterine rupture should be considered. Concomitant medication, maternal and foetal status should be taken into consideration in order to minimise the risk of uterine hyperstimulation, uterine rupture, uterine haemorrhage, foetal and neonatal death. Careful and regular monitoring of uterine activity and foetal heart rate should be conducted during use of dinoprostone. Patients who develop uterine hypertonus or hypercontractility, or in whom unusual foetal heart rate patterns develop, should be managed in a manner that addresses the welfare of the foetus and mother.</p><p>&nbsp;</p><p>Caution should be exercised in the administration of Prostin E2 Vaginal Tablets for the induction of labour in patients with:</p><ul><li>asthma or a history of asthma</li><li>epilepsy or a history of epilepsy</li><li>glaucoma or raised intra-ocular pressure</li><li>compromised cardiovascular, hepatic, or renal function</li><li>hypertension</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ruptured chorioamniotic membranes.</p><p>&nbsp;should be used with caution in patients with multiple pregnancy.</p><p>&nbsp;</p><p>In labour induction, cephalopelvic relationships should be carefully evaluated before use of Prostin E2 Vaginal Tablets. During use, uterine activity, foetal status and the progression of cervical dilation should be carefully monitored to detect possible evidence of undesired responses, e.g. hypertonus, sustained uterine contractions, or foetal distress.</p><p>&nbsp;</p><p>In cases where there is a known history of hypertonic uterine contractility or tetanic uterine contractions, it is recommended that uterine activity and the state of the foetus (where applicable) should be continuously monitored throughout labour. The possibility of uterine rupture should be borne in mind where high-tone uterine contractions are sustained.</p><p>&nbsp;</p><p>Women aged 35 years or older, those with complications during pregnancy and those with a gestational age over 40 weeks have been shown to have an increased risk of post-partum disseminated intravascular coagulation. In addition, these factors may further increase the risk associated with labour induction (see section 4.8). Therefore, in these women, use of dinoprostone should be undertaken with caution. Measures should be applied to detect as soon as possible an evolving fibrinolysis in the immediate post-partum phase.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The response to oxytocin may be accentuated in the presence of exogenous prostaglandin therapy. Concurrent use with other oxytocic agents is not recommended. A dosing interval of at least 6 hours is recommended in case of oxytocin use is considered necessary following dinoprostone administration. If used in sequence, the patient&#39;s uterine activity should be carefully monitored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p><u>&nbsp;</u></p><p>Prostin E2 Vaginal Tablets are only used during pregnancy, to induce labour.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p><u>&nbsp;</u></p><p>Prostaglandins are excreted in breast milk. This is not expected to be a hazard given the circumstances in which the product is used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The table below lists the adverse reactions identified through clinical trial experience and post-marketing surveillance by system organ class and frequency. Adverse reactions identified from post-marketing experience are included in italics. The frequency grouping is defined using the following convention: Very common (&ge;1/10); Common (&ge; 1/100 to &lt;1/10); Uncommon (&ge;1/1 000 to &lt;1/100); Rare (&ge; 1/10 000 to &lt;1/1 000); Very Rare (&lt; 1/10 000); and Not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p><strong>Table&nbsp;1. Adverse Reactions</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Very Common &ge;1/10</strong></p></td><td style="vertical-align:top"><p><strong>Common &ge;1/100 to &lt;1/10</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon &ge;1/1 000 to &lt;1/100</strong></p></td><td style="vertical-align:top"><p><strong>Rare </strong></p><p><strong>&ge;1/10 000 to &lt;1/1000</strong></p></td><td style="vertical-align:top"><p><strong>Very </strong></p><p><strong>Rare &lt;1/10 000</strong></p></td><td style="vertical-align:top"><p><strong>Frequency Not Known (Cannot Be Estimated From Available Data)</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Disseminated intravascular coagulation<!--[if supportFields]><span lang=EN-GB style='font-size:
  11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:major-bidi;
  mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-begin'></span> REF ref5 \h<span
  style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span style='mso-element:
  field-separator'></span></span><![endif]--><sup>* </sup><!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000500000072006500660035000000</w:data>
  </xml><![endif]--><!--[if supportFields]><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span><![endif]--></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypersensitivity, Anaphylactic reaction, Anaphylactic shock, Anaphylactoid reaction</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Cardiac arrest</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypertension<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref11 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>**</sup><sup><!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B020000000800000006000000720065006600310031000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]--></p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Asthma<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref11 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>**</sup><sup><!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B020000000800000006000000720065006600310031000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]-->, Bronchospasm<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref11 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>**</sup><sup><!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B020000000800000006000000720065006600310031000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]--></p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Nausea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rash</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Back pain</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Pregnancy, Puerperium and Perinatal conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uterine hypertonus, Foetal distress syndrome, Uterine contractions abnormal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uterine rupture, Premature separation of placenta, Anaphylactoid syndrome of pregnancy<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref11 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>**</sup><sup><!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B020000000800000006000000720065006600310031000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]-->, Rapid cervical dilatation, Neonatal distress, Death neonatal<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref10 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>&dagger;&dagger;<!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B020000000800000006000000720065006600310030000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]-->, Stillbirth<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref7 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>&dagger;<!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000500000072006500660037000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]-->, Foetal death</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Vulvovaginal burning sensation</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Irritation, Pain</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Foetal heart rate abnormal<!--[if supportFields]><sup><span
  lang=EN-GB style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";
  mso-ascii-theme-font:major-bidi;mso-hansi-font-family:"Times New Roman";
  mso-hansi-theme-font:major-bidi;mso-bidi-font-family:"Times New Roman";
  mso-bidi-theme-font:major-bidi;color:blue'><span style='mso-element:field-begin'></span>
  REF ref33 \h<span style='mso-spacerun:yes'>  </span>\* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>&dagger;<!--[if gte mso 9]><xml>
   <w:data>08D0C9EA79F9BACE118C8200AA004BA90B020000000800000006000000720065006600330033000000</w:data>
  </xml><![endif]--></sup><!--[if supportFields]><sup><span lang=EN-GB
  style='font-size:11.0pt;mso-ascii-font-family:"Times New Roman";mso-ascii-theme-font:
  major-bidi;mso-hansi-font-family:"Times New Roman";mso-hansi-theme-font:major-bidi;
  mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi;
  color:blue'><span style='mso-element:field-end'></span></span></sup><![endif]--></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Apgar score low</p></td></tr><tr><td colspan="7" style="vertical-align:top"><p>*<sup> </sup>Reported during post marketing surveillance</p><p>**<sup> </sup>Maternal adverse events that have been reported only with use of the vaginal tablets.</p><p>&dagger;<sup> </sup>Foetal adverse events that have been reported with use of the cervical gel, intravaginal gel and vaginal tablets.</p><p>&dagger;&dagger;<sup> </sup>Foetal adverse event has only been reported with vaginal tablets.</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to the National Pharmacovigilance Centre (NPC).</p><p>&nbsp;</p><p>To report side effects:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Center (NPC)</strong></p><p>SFDA Call center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><table border="1" cellspacing="0" cellpadding="0" align="left" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage may be expressed by uterine hypercontractility and uterine hypertonus. During use, uterine activity, foetal status and the progression of cervical dilation should be carefully monitored to detect possible evidence of undesired responses, e.g. hypertonus, sustained uterine contractions, or foetal distress. Because of the transient nature of prostaglandin E<sub>2</sub> (PGE<sub>2</sub>)-induced myometrial hyperstimulation, non-specific, conservative management was found to be effective in the vast majority of cases: i.e. maternal position change and administration of oxygen to the mother. If conservative management is not effective, &szlig;-adrenergic drugs may be used as a treatment of hyperstimulation following administration of PGE<sub>2</sub> for cervical ripening, in appropriate patients.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Prostaglandins, ATC-code: G02AD02</p><p>&nbsp;</p><p>Dinoprostone is a prostaglandin of the E series with actions on smooth muscle; the endogenous substance is termed prostaglandin E<sub>2</sub>. It induces contraction of uterine muscle at any stage of pregnancy and is reported to act predominantly as a vasodilator on blood vessels and as a bronchodilator on bronchial muscle. It is postulated that vaginal absorption of PGE<sub>2</sub> stimulates endogenous PGE<sub>2</sub> and PGF<sub>2</sub><sub>a</sub> production, similar to that which is seen in spontaneous labour.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Following insertion of the tablet, PGE<sub>2</sub> absorption (as measured by the presence of PGE<sub>2</sub> metabolites) increases to reach a peak at about 40 minutes. PGE<sub>2</sub> is rapidly metabolised to 13, 14-dihydro, 15-keto PGE<sub>2</sub> which is converted to 13, 14-dihydro, 15-keto PGA<sub>2</sub> which binds covalently to albumen.</p><p>&nbsp;</p><p>There has been found to be inter-patient variability regarding systemic absorption of PGE<sub>2</sub>. This can be attributed to different conditions of the vaginal mucosa between patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Animal studies lasting several weeks at high doses have shown that prostaglandins of the E and F series can induce proliferation of bone. Such effects have also been noted in newborn infants who received prostaglandin E<sub>1</sub> during prolonged treatment. There is no evidence that short-term administration of prostaglandin E<sub>2</sub> can cause similar bone effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose</p><p>Microcrystalline Cellulose</p><p>Colloidal Anhydrous Silica</p><p>Maize Starch</p><p>Magnesium Stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator at 2-8&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium foil strip of 4 tablets, each box containing 4 tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Wash hands thoroughly with soap and water after administration.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorisation Holder
Pfizer S.A, Brussels, Belgium

MANUFACTERED BY:
Sanico NV, Belgium

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>